The Wnt non-canonical signaling modulates cabazitaxel sensitivity in prostate cancer cells

BACKGROUND: Despite new drugs, metastatic prostate cancer remains fatal. Growing interest in the latest approved cabazitaxel taxane drug has markedly increased due to the survival benefits conferred when used at an earlier stage of the disease, its promising new therapeutic combination and formulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sennoune, Souad R., Nelius, Thomas, Jarvis, Courtney, Pruitt, Kevin, Kottapalli, Kameswara Rao, Filleur, Stéphanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266300/
https://www.ncbi.nlm.nih.gov/pubmed/32484838
http://dx.doi.org/10.1371/journal.pone.0234078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266300/
https://www.ncbi.nlm.nih.gov/pubmed/32484838
http://dx.doi.org/10.1371/journal.pone.0234078

Ejemplares similares